Hydrogen sulfide (H~2~S) is a colourless, flammable gas with a characteristic pungent smell. Until recently, the H~2~S literature was focused in the toxicology of this agent. Exposure to H~2~S concentrations lower than 100 ppm lead to eye irritation, sore throat, dizziness, nausea, shortness of breath, and chest tightness, while exposure to 1000 ppm or more causes central nervous system toxicity and respiratory depression. In the past 5 years the interest for H~2~S biology has seen an upsurge, as it was accepted that low amounts of this gas are endogenously produced in most mammalian tissues. Increasing evidence shows that H~2~S acts as a signalling molecule in cells and is now considered the third member of the gasotransmitter family along with nitric oxide and carbon monoxide. Most of H~2~S is produced by two enzymes cystathionine-synthase (CBS) and cystathionine γ-lyase (CSE) that use L-cysteine as a substrate and pyridoxal phosphate as a co-factor. CBS is highly expressed in the central nervous system, while CSE is abundantly present in the heart, lung, blood vessels, liver and kidney.

In the cardiovascular system, H~2~S has anti-apoptotic effects on cardiomyocytes, exerts cardioprotective actions and modifies vascular tone. We have recently shown that exogenously administered Na~2~S stimulates endothelial proliferation, migration and capillary-like network formation. These effects of H~2~S on migration are mediated through the activation of ATP-sensitive K^+^-channels (K~ATP~) and activation of mitogen activated protein kinase pathways. Inhibition of CSE and reduction of endogenously produced H~2~S reduces vascular network length and branching of blood vessels in the chicken chorioallantoic membrane. Exposure of endothelial cells to vascular endothelial growth factor (VEGF) increased H~2~S production and genetic or pharmacological inhibition of CSE restricted VEGF signalling and VEGF-driven angiogenic responses (migration, sprouting). Thus, H~2~S is an endogenous activator of angiogenesis and modulation of its production might be useful in diseases characterized by aberrant or excessive angiogenesis.

H~2~S exerts important biological actions in vascular smooth muscle cells. Originally H~2~S--induced vasorelaxation was believed to be mediated by potassium channels (including K~ATP~ channels). However, significant vasodilation can be observed after sulfonylurea treatment, suggesting that additional pathways are involved. We recently showed that H~2~S donors inhibit phosphodiesterase activity in vitro and that exposure to H~2~S increases cGMP levels in smooth muscle cells. The cGMP elevating effects of H~2~S are abolished following phosphodiesterase inhibition. Moreover, incubation of cells with H~2~S led to an increase in VASP phopshorylation on Ser239, suggesting that H~2~S activates PKG signalling pathways. More importantly, incubation of aortic rings with selective PKG-I inhibitors (DT-2, DT-3) attenuated H~2~S-induced vasorelaxation. Our results reinforce the notion that H~2~S plays important roles in vascular biology, by modulating vascular growth and tone.
